On ECHEMI
Home > Drugs > Lymphoma
Lymphoma
Lymphoma is a malignant tumor originating from lymph nodes or lymphatic tissues. The main clinical manifestation is painless, progressive lymphadenopathy. The disease can occur at any age, but the peak age of onset is between 31 and 40 years old, with the peak of non-Hodgkin's lymphoma slightly earlier. The male-to-female ratio is 2-3:1.
  • Site of disease:

    lymph
  • Infectious :

    Not contagious
  • Frequent population:

    Young Adults
  • Related symptoms:

    Lymph node enlargement hepatosplenomegaly weight loss night sweats persistent fever
Related Drugs
Methotrexate for injection
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia; malignant lymphoma, non-Hodgkin's lymphoma and mycosis fungoides, multiple myelopathy. 2. Malignant hydatidiform mole, choriocarcinoma, breast cancer, ovarian cancer, cervical cancer, testicular cancer. 3. Head and neck cancer, bronchial lung cancer, various soft tissue sarcomas. 4. High doses are used for osteosarcoma, intrathecal injection can be used to prevent and treat meningeal leukemia and nerve invasion of malignant lymphoma, this product also has a certain effect on psoriasis.
Methotrexate for injection
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia; malignant lymphoma, non-Hodgkin's lymphoma and mycosis fungoides, multiple myelopathy. 2. Malignant hydatidiform mole, choriocarcinoma, breast cancer, ovarian cancer, cervical cancer, testicular cancer. 3. Head and neck cancer, bronchial lung cancer, various soft tissue sarcomas. 4. High doses are used for osteosarcoma, intrathecal injection can be used to prevent and treat meningeal leukemia and nerve invasion of malignant lymphoma, this product also has a certain effect on psoriasis.
Manufacturer:

Qilu Pharmaceutical Co., Ltd.

Cisplatin Injection
Indication: It has a wide anti-tumor spectrum and is clinically used to treat testicular malignant tumors. It has good effects on embryonal tumors and seminoma, and has no cross-resistance with commonly used drugs. It has good effects on ovarian cancer, breast cancer and bladder cancer. It also has certain effects on head and neck cancer, lung cancer, esophageal cancer, malignant melanoma, malignant lymphoma, soft tissue sarcoma and cancerous pleural effusion and ascites. It has good effects when used in combination with other anticancer drugs.
Vincristine Sulfate for Injection
Indication: ①. Acute leukemia, especially childhood acute leukemia, and has significant efficacy on acute lymphocytic leukemia. ②. Malignant lymphoma. ③. Germ cell tumors. ④. Small cell lung cancer, Ewing sarcoma, Wilms tumor, neuroblastoma. ⑤. Breast cancer, chronic lymphocytic leukemia, digestive tract cancer, melanoma, multiple myeloma, etc.
Manufacturer:

Fresenius Kabi (Wuhan) Pharmaceutical Co., Ltd.

Vincristine Sulfate for Injection
Indication: ①. Acute leukemia, especially childhood acute leukemia, and has significant efficacy on acute lymphocytic leukemia. ②. Malignant lymphoma. ③. Germ cell tumors. ④. Small cell lung cancer, Ewing sarcoma, Wilms tumor, neuroblastoma. ⑤. Breast cancer, chronic lymphocytic leukemia, digestive tract cancer, melanoma, multiple myeloma, etc.
Manufacturer:

ShenZhen Main Luck Pharmaceuticals Inc

Vincristine Sulfate for Injection
Indication: 1. Acute leukemia, especially childhood acute leukemia, and has significant efficacy on acute lymphocytic leukemia. 2. Malignant lymphoma. 3. Germ cell tumors. 4. Small cell lung cancer, Ewing sarcoma, Wilms tumor, neuroblastoma. 5. Breast cancer, chronic lymphocytic leukemia, digestive tract cancer, melanoma, multiple myeloma, etc.
Vincristine Sulfate for Injection
Indication: 1. Acute leukemia, especially childhood acute leukemia, and has significant efficacy on acute lymphocytic leukemia. 2. Malignant lymphoma. 3. Germ cell tumors. 4. Small cell lung cancer, Ewing sarcoma, Wilms tumor, neuroblastoma. 5. Breast cancer, chronic lymphocytic leukemia, digestive tract cancer, melanoma, multiple myeloma, etc.
Manufacturer:

Guangdong Lingnan Pharmaceutical Co., Ltd.

Vincristine Sulfate for Injection
Indication: ①. Acute leukemia, especially childhood acute leukemia, and has significant efficacy on acute lymphocytic leukemia. ②. Malignant lymphoma. ③. Germ cell tumors. ④. Small cell lung cancer, Ewing sarcoma, Wilms tumor, neuroblastoma. ⑤. Breast cancer, chronic lymphocytic leukemia, digestive tract cancer, melanoma, multiple myeloma, etc.
Manufacturer:

Shanxi PUDE Pharmaceutical Co., Ltd.

Vincristine Sulfate for Injection
Indication: ①. Acute leukemia, especially childhood acute leukemia, and has significant efficacy on acute lymphocytic leukemia. ②. Malignant lymphoma. ③. Germ cell tumors. ④. Small cell lung cancer, Ewing sarcoma, Wilms tumor, neuroblastoma. ⑤. Breast cancer, chronic lymphocytic leukemia, digestive tract cancer, melanoma, multiple myeloma, etc.
Manufacturer:

Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.

Vincristine Sulfate for Injection
Indication: 1. Acute leukemia, especially childhood acute leukemia, and has significant efficacy on acute lymphocytic leukemia. 2. Malignant lymphoma. 3. Germ cell tumors. 4. Small cell lung cancer, Ewing sarcoma, Wilms tumor, neuroblastoma. 5. Breast cancer, chronic lymphocytic leukemia, digestive tract cancer, melanoma, multiple myeloma, etc.
Manufacturer:

Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.